Measurement of fecal alpha-1-antitrypsin (A1AT) excretion has been demonstrated to be a reliable, non-invasive test for protein-losing enteropathy in humans. The unique biologic properties of A1AT ...

This technology is directed towards a potential treatment for a new disease, CHAPLE (Complement Hyperactivation, Angiopathic thrombosis, and Protein-Losing Enteropathy), identified by NIAID ...

It's an inflammatory bowel disease causing protein-losing enteropathy. Alicia manages Dorothy's disease using daily medication and a special diet of home cooking. She says her medical expenses for ...